News Outlets Report On Various Aspects Of Research Into Novel Coronavirus Vaccines, Therapies

Bloomberg: Covid-Vaccine Developer in India Plans to Boost Capacity by 70% (Kay, 10/26).

CNBC: AstraZeneca says its coronavirus vaccine triggers immune response among adults (Meredith, 10/26).

CNN: CNN interviews chief of institute developing Russia’s Sputnik V vaccine (Pleitgen, 10/26).

Financial Times: Mexico uses human trials as path to secure future Covid-19 vaccines (Webber/Pulice, 10/26).

Financial Times: U.S. experts urge caution on giving Covid vaccine to children (Kuchler, 10/27).

HealthDay News: What Will It Take for People to Embrace a COVID Vaccine? (Murez, 10/26).

Homeland Preparedness News: CEPI reaches manufacturing agreements for COVID-19 vaccines (Kovaleski, 10/23).

Scientific American: A Flu Shot Might Reduce Coronavirus Infections, Early Research Suggests (Moyer, 10/27).

POLITICO: Game-changing coronavirus medicine gears up for production (Martuscelli, 10/23).

Wall Street Journal: Covid-19 Vaccine Makers See Egypt as Crucial Launchpad (Malsin, 10/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.